The European Medicines Agency's approval of new medicines for type 2 diabetes
Author:
Affiliation:
1. European Medicines Agency; London UK
2. Medical Products Agency; Uppsala Sweden
3. Dutch Medicines Evaluation Board; Utrecht The Netherlands
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13349/fullpdf
Reference31 articles.
1. Health at a Glance: Europe 2016
2. Effects of Sotagliflozin added to insulin in patients with type 1 diabetes;Garg;N Engl J Med,2017
3. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes;Inzucchi;Diabetologia,2015
4. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of diabetes;Nathan;Diabetologia,2006
5. Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas;Deacon;Diabetes Obes Metab,2016
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The hypoglycemic potential of Syzygium cordatum (Hochst. ex Krauss.) extracts; in vitro analysis and in silico modelling;South African Journal of Botany;2024-11
2. Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries—A Cross-Sectional Comparison;Pharmaceuticals;2024-06-17
3. An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database;Biomedicines;2024-05-18
4. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options;Frontiers in Cardiovascular Medicine;2023-07-27
5. Predictive Modeling of Diabetes Onset and Survival Analysis Among Diabetic Patients;2023 Congress in Computer Science, Computer Engineering, & Applied Computing (CSCE);2023-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3